 Joanne Cole
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Specimen Banks | 3 | 2021 | 102 | 1.340 |
Why?
| | Genome-Wide Association Study | 15 | 2022 | 1431 | 1.180 |
Why?
| | Diabetes Mellitus, Type 2 | 11 | 2023 | 2534 | 1.110 |
Why?
| | Face | 3 | 2017 | 173 | 1.050 |
Why?
| | Diabetic Nephropathies | 5 | 2022 | 294 | 0.680 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 380 | 0.650 |
Why?
| | Maxillofacial Development | 2 | 2016 | 18 | 0.640 |
Why?
| | Diabetes Complications | 1 | 2020 | 227 | 0.580 |
Why?
| | Genetic Association Studies | 1 | 2020 | 377 | 0.570 |
Why?
| | Facial Bones | 1 | 2017 | 30 | 0.560 |
Why?
| | 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2016 | 12 | 0.520 |
Why?
| | Malnutrition | 1 | 2017 | 83 | 0.510 |
Why?
| | Quantitative Trait, Heritable | 1 | 2016 | 125 | 0.490 |
Why?
| | Genomics | 1 | 2020 | 795 | 0.450 |
Why?
| | Genetic Predisposition to Disease | 8 | 2023 | 2427 | 0.440 |
Why?
| | Diet | 2 | 2021 | 1279 | 0.440 |
Why?
| | Feeding Behavior | 1 | 2020 | 655 | 0.430 |
Why?
| | Genetic Loci | 4 | 2022 | 288 | 0.410 |
Why?
| | Polymorphism, Single Nucleotide | 8 | 2022 | 2189 | 0.400 |
Why?
| | Child Development | 1 | 2017 | 475 | 0.390 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2111 | 0.390 |
Why?
| | Genetic Variation | 2 | 2021 | 991 | 0.390 |
Why?
| | Carrier Proteins | 1 | 2016 | 771 | 0.380 |
Why?
| | United Kingdom | 2 | 2021 | 318 | 0.320 |
Why?
| | Genotype | 5 | 2022 | 1917 | 0.310 |
Why?
| | Phenotype | 6 | 2022 | 3196 | 0.310 |
Why?
| | Tanzania | 3 | 2017 | 58 | 0.300 |
Why?
| | Multifactorial Inheritance | 2 | 2022 | 174 | 0.220 |
Why?
| | Mendelian Randomization Analysis | 2 | 2021 | 50 | 0.210 |
Why?
| | Dyslipidemias | 2 | 2022 | 176 | 0.200 |
Why?
| | Adipose Tissue, Beige | 1 | 2022 | 2 | 0.200 |
Why?
| | Humans | 25 | 2023 | 137782 | 0.190 |
Why?
| | Obesity | 5 | 2023 | 2993 | 0.190 |
Why?
| | Genes, Recessive | 1 | 2022 | 78 | 0.190 |
Why?
| | Hyperuricemia | 1 | 2021 | 44 | 0.170 |
Why?
| | Gout | 1 | 2021 | 37 | 0.170 |
Why?
| | Gene-Environment Interaction | 1 | 2022 | 192 | 0.170 |
Why?
| | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2020 | 11 | 0.170 |
Why?
| | Metabolome | 2 | 2022 | 350 | 0.170 |
Why?
| | Disease | 1 | 2021 | 98 | 0.170 |
Why?
| | Loss of Function Mutation | 1 | 2020 | 46 | 0.160 |
Why?
| | Inheritance Patterns | 1 | 2020 | 45 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 179 | 0.160 |
Why?
| | Glomerular Basement Membrane | 1 | 2019 | 8 | 0.160 |
Why?
| | Receptors, Odorant | 1 | 2020 | 32 | 0.160 |
Why?
| | Collagen Type IV | 1 | 2019 | 28 | 0.160 |
Why?
| | Principal Component Analysis | 1 | 2020 | 195 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 94 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2021 | 347 | 0.150 |
Why?
| | Genome, Human | 1 | 2021 | 425 | 0.150 |
Why?
| | Multigene Family | 1 | 2018 | 198 | 0.140 |
Why?
| | Diabetic Retinopathy | 1 | 2020 | 189 | 0.140 |
Why?
| | Cross-Sectional Studies | 5 | 2023 | 5478 | 0.140 |
Why?
| | Growth | 1 | 2017 | 60 | 0.140 |
Why?
| | Eating | 1 | 2020 | 380 | 0.130 |
Why?
| | Body Size | 1 | 2017 | 108 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 2 | 2017 | 584 | 0.130 |
Why?
| | Biomarkers | 3 | 2022 | 4154 | 0.130 |
Why?
| | Autoantigens | 1 | 2019 | 430 | 0.130 |
Why?
| | Anthropometry | 1 | 2016 | 213 | 0.120 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2022 | 3717 | 0.120 |
Why?
| | Female | 9 | 2022 | 73465 | 0.120 |
Why?
| | Morphogenesis | 1 | 2016 | 166 | 0.120 |
Why?
| | Body Mass Index | 2 | 2021 | 2390 | 0.120 |
Why?
| | DNA-Binding Proteins | 1 | 2022 | 1502 | 0.110 |
Why?
| | Adolescent | 4 | 2017 | 21574 | 0.110 |
Why?
| | Coronary Artery Disease | 1 | 2021 | 698 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 617 | 0.110 |
Why?
| | Risk Factors | 4 | 2023 | 10407 | 0.110 |
Why?
| | Transcription Factors | 1 | 2022 | 1719 | 0.110 |
Why?
| | Child, Preschool | 3 | 2017 | 11105 | 0.110 |
Why?
| | Male | 8 | 2022 | 67906 | 0.100 |
Why?
| | Young Adult | 3 | 2017 | 13240 | 0.090 |
Why?
| | Stroke | 1 | 2021 | 1120 | 0.090 |
Why?
| | Vitiligo | 1 | 2012 | 42 | 0.090 |
Why?
| | Mutation | 2 | 2022 | 3959 | 0.090 |
Why?
| | Prospective Studies | 2 | 2021 | 7623 | 0.090 |
Why?
| | Aging | 1 | 2021 | 1865 | 0.080 |
Why?
| | Gene Frequency | 2 | 2022 | 521 | 0.080 |
Why?
| | Causality | 2 | 2021 | 126 | 0.080 |
Why?
| | Cluster Analysis | 2 | 2022 | 501 | 0.080 |
Why?
| | Haplotypes | 2 | 2021 | 494 | 0.080 |
Why?
| | Child | 3 | 2017 | 21989 | 0.080 |
Why?
| | Bayes Theorem | 2 | 2022 | 407 | 0.070 |
Why?
| | Adult | 5 | 2022 | 38023 | 0.070 |
Why?
| | DNA Methylation | 2 | 2022 | 643 | 0.060 |
Why?
| | Middle Aged | 3 | 2022 | 33554 | 0.060 |
Why?
| | Mice | 2 | 2022 | 17794 | 0.050 |
Why?
| | Adipocytes, Beige | 1 | 2022 | 1 | 0.050 |
Why?
| | Cullin Proteins | 1 | 2022 | 12 | 0.050 |
Why?
| | CpG Islands | 1 | 2022 | 157 | 0.050 |
Why?
| | Thermogenesis | 1 | 2022 | 44 | 0.050 |
Why?
| | Ubiquitination | 1 | 2022 | 102 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2022 | 53 | 0.050 |
Why?
| | Insulin Resistance | 2 | 2022 | 1211 | 0.050 |
Why?
| | Protein Stability | 1 | 2022 | 176 | 0.050 |
Why?
| | Homozygote | 1 | 2022 | 203 | 0.050 |
Why?
| | Penetrance | 1 | 2021 | 28 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2021 | 21 | 0.040 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2021 | 16 | 0.040 |
Why?
| | Gout Suppressants | 1 | 2021 | 20 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2022 | 146 | 0.040 |
Why?
| | Europe | 1 | 2022 | 414 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 36 | 0.040 |
Why?
| | Exome | 1 | 2021 | 231 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 186 | 0.040 |
Why?
| | Uric Acid | 1 | 2021 | 163 | 0.040 |
Why?
| | Cholesterol, LDL | 1 | 2022 | 365 | 0.040 |
Why?
| | Pedigree | 1 | 2021 | 514 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 524 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 552 | 0.040 |
Why?
| | Heterozygote | 1 | 2020 | 293 | 0.040 |
Why?
| | Embryonic Stem Cells | 1 | 2020 | 129 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 455 | 0.040 |
Why?
| | Founder Effect | 1 | 2018 | 11 | 0.040 |
Why?
| | Alleles | 1 | 2022 | 892 | 0.040 |
Why?
| | Longevity | 1 | 2020 | 165 | 0.040 |
Why?
| | Animals | 2 | 2022 | 36951 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 1290 | 0.040 |
Why?
| | Precision Medicine | 1 | 2022 | 433 | 0.040 |
Why?
| | Cohort Studies | 2 | 2019 | 5750 | 0.040 |
Why?
| | Anthropology, Physical | 1 | 2017 | 28 | 0.040 |
Why?
| | Lymphocytes | 1 | 2020 | 397 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 660 | 0.030 |
Why?
| | Biometry | 1 | 2017 | 70 | 0.030 |
Why?
| | Genetic Markers | 1 | 2018 | 344 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2018 | 237 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2734 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2077 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1459 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2020 | 526 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 644 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 678 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2847 | 0.030 |
Why?
| | Kidney | 1 | 2022 | 1475 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2020 | 498 | 0.030 |
Why?
| | Biological Evolution | 1 | 2017 | 475 | 0.030 |
Why?
| | Age Factors | 1 | 2021 | 3305 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2836 | 0.020 |
Why?
| | Eye Color | 1 | 2012 | 3 | 0.020 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2012 | 55 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3461 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1704 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7637 | 0.020 |
Why?
| | Insulin | 1 | 2018 | 2411 | 0.020 |
Why?
| | Aged | 1 | 2020 | 24001 | 0.010 |
Why?
| | United States | 1 | 2017 | 14870 | 0.010 |
Why?
|
|
Cole's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|